Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
SynuCa Therapeutics Logo
SynuCa Therapeutics Growth Score
86
CB Rank
38282
Heat Score
61
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Founded
obfuscation
PrivateSeed Aarhus, Midtjylland, Denmark1-10 www.synuca.com
Medical
Neuroscience
Therapeutics
Overview

SynuCa Therapeutics
Total Funding
obfuscation
Growth Score
86
Heat Score
61

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score86
-9 pts
in past quarter
Heat Score 61
-29 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About SynuCa Therapeutics

CB Rank
38282
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Founded
obfuscation
PrivateSeed Aarhus, Midtjylland, Denmark1-10 www.synuca.com
Medical
Neuroscience
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Predictions & Insights

Growth Insight

See this Growth Insight
SynuCa Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Disease-Modifying Treatment Targeting SERCA Calcium Transporter
A small molecule therapy designed to repair neuronal calcium imbalances caused by pathological α-Synuclein in Parkinson's disease patients.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed
obfuscation
Seed Round - SynuCa Therapeutics Logo
Seed Round - SynuCa Therapeutics
1
obfuscation
BioInnovation Institute Venture LabSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Apr 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

373

Active Website Tech Count

2SynuCa Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is SynuCa Therapeutics's headquarters? SynuCa Therapeutics is located in Aarhus, Midtjylland, Denmark.Who invested in SynuCa Therapeutics? SynuCa Therapeutics is funded by BioInnovation Institute Venture Lab.When was the last funding round for SynuCa Therapeutics? SynuCa Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are SynuCa Therapeutics's competitors? Alternatives and possible competitors to SynuCa Therapeutics may include AbbVie, Roche, and  Cerevance.How much funding has SynuCa Therapeutics raised to date? SynuCa Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|